title: Suppression of rat bone marrow cells by Friend murine leukemia virus envelope proteins.
abstract: In a retroviral rat model, we have investigated the nontransforming effects of murine leukemia virus FB29 on the bone marrow. Upon intraperitoneal inoculation with murine leukemia virus FB29 of either neonatal or adult rats, bone marrow cells became massively infected within the first 12 days postinoculation. In neonatally inoculated rats, a persistent productive bone marrow infection was established, whereas in rats inoculated as adults, no infected bone marrow cells could be detected beyond 12 days postinoculation. Retroviral infection was most likely cleared by an antiviral immune response (Hein et al., 1995, Virology 211, 408-417). Exposure to virus irreversibly decreased numbers of bone marrow cells staining with monoclonal antibody OX7 by 10-30%. Reduction of OX7+ bone marrow cells by 20% was also observed in vitro, after bone marrow cells from uninfected adult rats had been co-incubated with virus. FB29-envelope proteins were sufficient alone to reduce numbers of OX7+ bone marrow cells, both in vivo and in vitro. According to results on incorporation of propidium iodide, decreased numbers of OX7+ cells were due to cell death. By flow cytometric analyses OX7+ bone marrow cells as well as monocytes/macrophages were identified to be major target cells for infection with FB29 within the bone marrow. Thus, the mechanism(s) responsible for death of OX7+ bone marrow cells might be due to direct toxicity of viral envelope proteins and/or to interactions of viral envelope proteins with cells of the monocytic lineage.
authors.affiliation: Institut für Virologie und Immunbiologie, Universität Würzburg, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Mazgareanu
authors.forename: J G
authors.initials: JG
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Czub
authors.forename: S
authors.initials: S
authors.lastname: Schimmer
authors.forename: M
authors.initials: M
authors.lastname: Bredt
authors.forename: M
authors.initials: M
authors.lastname: Czub
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001854:Bone Marrow Cells / Q000473:pathology / Q000821:virology*; D016923:Cell Death; D002478:Cells, Cultured; D005434:Flow Cytometry; D005622:Friend murine leukemia virus / Q000472:pathogenicity*; D015151:Immunoblotting; D008264:Macrophages / Q000473:pathology / Q000821:virology*; D051379:Mice; D051381:Rats; D011916:Rats, Inbred F344; D012192:Retroviridae Infections / Q000473:pathology / Q000821:virology*; D018800:Thy-1 Antigens / Q000276:immunology / Q000378:metabolism; D013997:Time Factors; D014412:Tumor Virus Infections / Q000473:pathology / Q000821:virology*; D014759:Viral Envelope Proteins / Q000502:physiology*
chemical_list: D018800:Thy-1 Antigens; D014759:Viral Envelope Proteins